Literature DB >> 20817082

Effects of Scutellariae radix and Aloe vera gel extracts on immunoglobulin E and cytokine levels in atopic dermatitis NC/Nga mice.

Jinkyung Kim1, In seok Lee, Soojin Park, Ryowon Choue.   

Abstract

AIM OF THE STUDY: The present study aimed to investigate the effects of Scutellariae radix (SR) and Aloe vera gel (AV), alone or in combination, on levels of immunoglobulin E (IgE) and inflammatory cytokines in spontaneous atopic dermatitis(AD)-like skin lesions.
MATERIALS AND METHODS: After spontaneous AD-like skin lesion was developed by adaptation to conventional conditions, mice were randomly assigned to control, SR (50 mg/kg, p.o.), AV (0.8 mg/kg, p.o.) and SRAV (50 mg of SR and 0.8 mg of AV/kg, p.o.) groups, and were treated for 6 weeks.
RESULTS: SR and SRAV suppressed IL-5 levels compared with control, but had no effects on IgE levels (P<0.05). AV increased IgE levels, but decreased both IL-5 and IL-10 compared with control (P<0.05).
CONCLUSION: These results suggest that SR and AV modulate immunological responses in AD, mainly through influencing IL-5 or IL-10 levels.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20817082     DOI: 10.1016/j.jep.2010.08.049

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  16 in total

1.  A comparison of the leaf gel extracts of Aloe ferox and Aloe vera in the topical treatment of atopic dermatitis in Balb/c mice.

Authors:  M J Finberg; G L Muntingh; C E J van Rensburg
Journal:  Inflammopharmacology       Date:  2015-10-28       Impact factor: 4.473

2.  Augmented humoral immune response and decreased cell-mediated immunity by Aloe vera in rats.

Authors:  Sumita Halder; Ashish K Mehta; Pramod K Mediratta
Journal:  Inflammopharmacology       Date:  2012-04-04       Impact factor: 4.473

3.  Acute effect of Aloe vera gel extract on experimental models of pain.

Authors:  Naveen Rathor; Ashish K Mehta; Amit K Sharma; Pramod K Mediratta; Krishna K Sharma
Journal:  Inflammation       Date:  2012-12       Impact factor: 4.092

4.  A Herbal Composition of Scutellaria baicalensis and Eleutherococcus senticosus Shows Potent Anti-Inflammatory Effects in an Ex Vivo Human Mucosal Tissue Model.

Authors:  Nan Zhang; Koen Van Crombruggen; Gabriele Holtappels; Claus Bachert
Journal:  Evid Based Complement Alternat Med       Date:  2012-01-05       Impact factor: 2.629

5.  Topical Application of Chrysanthemum indicum L. Attenuates the Development of Atopic Dermatitis-Like Skin Lesions by Suppressing Serum IgE Levels, IFN-γ, and IL-4 in Nc/Nga Mice.

Authors:  Sunmin Park; Jung Bok Lee; Suna Kang
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-09       Impact factor: 2.629

6.  Traditional Herbal Formula Banhasasim-tang Exerts Anti-Inflammatory Effects in RAW 264.7 Macrophages and HaCaT Keratinocytes.

Authors:  Seong Eun Jin; Hye-Sun Lim; Yeji Kim; Chang-Seob Seo; Sae-Rom Yoo; Hyeun-Kyoo Shin; Soo-Jin Jeong
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-09       Impact factor: 2.629

Review 7.  Plants used to treat skin diseases.

Authors:  Nahida Tabassum; Mariya Hamdani
Journal:  Pharmacogn Rev       Date:  2014-01

8.  Skullcapflavone II Suppresses TNF-α/IFN-γ-Induced TARC, MDC, and CTSS Production in HaCaT Cells.

Authors:  Hanon Lee; Dong Hun Lee; Jang-Hee Oh; Jin Ho Chung
Journal:  Int J Mol Sci       Date:  2021-06-16       Impact factor: 6.208

9.  Application of Scutellariae radix, Gardeniae fructus, and Probiotics to Prevent Salmonella enterica Serovar Choleraesuis Infection in Swine.

Authors:  Chiung-Hung Chang; Yueh-Sheng Chen; Ming-Tang Chiou; Chiu-Hsian Su; Daniel S Chen; Chin-En Tsai; Bi Yu; Yuan-Man Hsu
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-26       Impact factor: 2.629

Review 10.  Emollient treatment of atopic dermatitis: latest evidence and clinical considerations.

Authors:  Kam Lun Hon; Jeng Sum Charmaine Kung; Wing Gi Gigi Ng; Ting Fan Leung
Journal:  Drugs Context       Date:  2018-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.